From Failure to Promise: Obicetrapib and the Renaissance of Cholesteryl Ester Transfer Protein Inhibition in Atherosclerotic Cardiovascular Disease. [PDF]
J Am Heart AssocPrajapathi S +3 more
europepmc +1 more source
Apolipoprotein B is considered a potential therapeutic drug target for the treatment of AML. [PDF]
Discov OncolMeng Q, Zhou Z, Zhang W.
europepmc +1 more source
HDL and ASCVD: is high HDL-C protective, harmful, or simply misleading? [PDF]
Curr Opin LipidolParini P, Pedrelli M.
europepmc +1 more source
The Impact of Current and Emerging Therapies on Lipoprotein(a). [PDF]
Eur CardiolNicholls SJ, Nelson AJ.
europepmc +1 more source
Genetic testing in individuals with extreme HDL-C levels: Diagnostic yield and clinical implications from the Tromsø Study. [PDF]
PLoS OneØlnes ÅS +6 more
europepmc +1 more source
Altered small dense LDL profiles in long-standing controlled type 1 diabetes. [PDF]
Front Endocrinol (Lausanne)Sardà H +9 more
europepmc +1 more source
Integrating multi-omics and machine learning to explore the role of amino acid metabolism in intervertebral disk degeneration. [PDF]
Front NeurolLi X +8 more
europepmc +1 more source
Drug targets for lipid modification and risk of type 2 diabetes: a cis-Mendelian randomization study. [PDF]
Cardiovasc DiabetolChen Z +9 more
europepmc +1 more source
The emerging role of CETP inhibition in the prevention of Alzheimer's disease. [PDF]
Am J Prev CardiolDavidson MH +8 more
europepmc +1 more source